|
|
|
|
|
|
by dumb1224
1858 days ago
|
|
|
Depends on the industry as well. Cell counting is a huge part of life science research and it's a well established business in lab-based pipelines (integral part of commercial solutions). However if you try to enter the realm of clinical field such as histology and pathology assistive technology it suddenly becomes tricky. Same with innovative diagnostic tools. You need clinical trials for those. |
|
|